DE69732662D1 - Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen - Google Patents

Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen

Info

Publication number
DE69732662D1
DE69732662D1 DE69732662T DE69732662T DE69732662D1 DE 69732662 D1 DE69732662 D1 DE 69732662D1 DE 69732662 T DE69732662 T DE 69732662T DE 69732662 T DE69732662 T DE 69732662T DE 69732662 D1 DE69732662 D1 DE 69732662D1
Authority
DE
Germany
Prior art keywords
fetal
fetal cells
identification
proteins
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69732662T
Other languages
English (en)
Other versions
DE69732662T2 (de
Inventor
Mitchell Golbus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Imaging Inc
Original Assignee
Applied Imaging Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Imaging Corp filed Critical Applied Imaging Corp
Application granted granted Critical
Publication of DE69732662D1 publication Critical patent/DE69732662D1/de
Publication of DE69732662T2 publication Critical patent/DE69732662T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69732662T 1996-10-21 1997-10-20 Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen Expired - Fee Related DE69732662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US734556 1996-10-21
US08/734,556 US5731156A (en) 1996-10-21 1996-10-21 Use of anti-embryonic hemoglobin antibodies to identify fetal cells
PCT/US1997/019447 WO1998018005A1 (en) 1996-10-21 1997-10-20 Use of anti-embryonic hemoglobin antibodies to identify fetal cells

Publications (2)

Publication Number Publication Date
DE69732662D1 true DE69732662D1 (de) 2005-04-07
DE69732662T2 DE69732662T2 (de) 2005-12-29

Family

ID=24952172

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732662T Expired - Fee Related DE69732662T2 (de) 1996-10-21 1997-10-20 Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen

Country Status (14)

Country Link
US (1) US5731156A (de)
EP (1) EP1007965B1 (de)
JP (1) JP4091123B2 (de)
KR (1) KR100523381B1 (de)
CN (1) CN1234117A (de)
AT (1) ATE290210T1 (de)
AU (1) AU735380B2 (de)
BR (1) BR9712548A (de)
CA (1) CA2269327A1 (de)
DE (1) DE69732662T2 (de)
HK (1) HK1031255A1 (de)
IL (1) IL129382A (de)
RU (1) RU2178703C2 (de)
WO (1) WO1998018005A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US5629147A (en) * 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US6718053B1 (en) * 1996-11-27 2004-04-06 Chromavision Medical Systems, Inc. Method and apparatus for automated image analysis of biological specimens
WO1997020198A2 (en) * 1995-11-30 1997-06-05 Chromavision Medical Systems, Inc. Method and apparatus for automated image analysis of biological specimens
CN1260046A (zh) * 1997-03-08 2000-07-12 邓迪大学 出生前诊断法
US5962234A (en) * 1997-10-20 1999-10-05 Applied Imaging Corporation Use of anti-embryonic epsilon hemoglobin antibodies to identify fetal cells
JP2002514762A (ja) * 1998-05-09 2002-05-21 アイコニシス，インコーポレーテッド コンピュータによって制御された、胎児細胞を含む希少細胞に基づく診断のための方法および装置
FR2781055B1 (fr) * 1998-07-09 2000-10-13 Immunotech Sa Reactif et methode pour la permeabilisation et l'identification des erythrocytes
CA2413835A1 (en) * 1999-05-25 2000-11-30 Britta Christensen Isolation and culturing of fetal cells
US6692952B1 (en) * 1999-11-10 2004-02-17 Massachusetts Institute Of Technology Cell analysis and sorting apparatus for manipulation of cells
DE10035433C2 (de) * 2000-07-20 2002-07-18 Tuma Wolfgang Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben
EP1462800A4 (de) * 2001-12-11 2007-01-17 Netech Inc System zur trennung von blutzellen
WO2004029221A2 (en) 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US10966421B2 (en) 2002-10-16 2021-04-06 Streck, Inc. Method and device for collecting and preserving cells for analysis
US20040214243A1 (en) * 2003-04-25 2004-10-28 Beckman Coulter, Inc. Differential determination of hemoglobins
CA2529285A1 (en) * 2003-06-13 2004-12-29 The General Hospital Corporation Microfluidic systems for size based removal of red blood cells and platelets from blood
US20050266433A1 (en) * 2004-03-03 2005-12-01 Ravi Kapur Magnetic device for isolation of cells and biomolecules in a microfluidic environment
US7653260B2 (en) * 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) * 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
US20070026414A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026413A1 (en) * 2005-07-29 2007-02-01 Mehmet Toner Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US20070026415A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070026417A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059680A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for cell enrichment
US20070026416A1 (en) * 2005-07-29 2007-02-01 Martin Fuchs Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20090181421A1 (en) * 2005-07-29 2009-07-16 Ravi Kapur Diagnosis of fetal abnormalities using nucleated red blood cells
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070059716A1 (en) * 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
US20070059774A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Kits for Prenatal Testing
US20070059719A1 (en) * 2005-09-15 2007-03-15 Michael Grisham Business methods for prenatal Diagnosis
US20070059781A1 (en) * 2005-09-15 2007-03-15 Ravi Kapur System for size based separation and analysis
US20070059683A1 (en) * 2005-09-15 2007-03-15 Tom Barber Veterinary diagnostic system
US20070059718A1 (en) * 2005-09-15 2007-03-15 Mehmet Toner Systems and methods for enrichment of analytes
ATE528722T1 (de) * 2007-05-14 2011-10-15 Historx Inc Abteilungsauftrennung durch pixelcharakterisierung unter verwendung von bilddatenclusterung
JP5593221B2 (ja) * 2007-06-15 2014-09-17 ヒストロックス，インコーポレイテッド． 顕微鏡機器を標準化するための方法およびシステム
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) * 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
US7978258B2 (en) * 2007-08-31 2011-07-12 Historx, Inc. Automatic exposure time selection for imaging tissue
WO2009085745A1 (en) * 2007-12-20 2009-07-09 Cytyc Corporation Method for magnetic separation of red blood cells from a patient sample
EP2250497B1 (de) * 2008-02-18 2014-09-10 Genetic Technologies Limited Zellprozessierungs- und/oder -anreicherungsverfahren
US20100159506A1 (en) * 2008-07-25 2010-06-24 Cellscape Corporation Methods and systems for genetic analysis of fetal nucleated red blood cells
WO2010033508A1 (en) * 2008-09-16 2010-03-25 Historx, Inc. Reproducible quantification of biomarker expression
US20100167271A1 (en) * 2008-12-30 2010-07-01 Streck, Inc. Method for screening blood using a preservative that may be in a substantially solid state form
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
EP2389455A4 (de) * 2009-01-26 2012-12-05 Verinata Health Inc Verfahren und zusammensetzung zur identifizierung einer fetalen zelle
US8231007B2 (en) * 2009-01-29 2012-07-31 Wark Rickey E Static classifier cage
DK3290530T3 (da) 2009-02-18 2020-12-07 Streck Inc Konservering af cellefrie nukleinsyrer
EP2421955A4 (de) 2009-04-21 2012-10-10 Genetic Technologies Ltd Verfahren zur gewinnung von fötalem genmaterial
EP2446267A1 (de) * 2009-06-24 2012-05-02 Health Corporation - Rambam Verfahren und kits zur isolation von plazentalen mikropartikeln und ihre verwendung zur diagnose von fetalen erkrankungen
WO2011057184A1 (en) * 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
JP5846609B2 (ja) 2010-01-21 2016-01-20 バイオセップ リミテッド 希少細胞の磁気分離
US8774488B2 (en) 2010-03-11 2014-07-08 Cellscape Corporation Method and device for identification of nucleated red blood cells from a maternal blood sample
EP2561095A1 (de) * 2010-04-20 2013-02-27 Ventana Medical Systems, Inc. Zweifarbige, chromgene in-situ-hybridisierung
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
SG11201403465PA (en) * 2011-12-23 2014-10-30 Atrm Llc Detection of human umbilical cord tissue-derived cells
WO2013192342A1 (en) * 2012-06-20 2013-12-27 Celula, Inc. Materials and methods for processing cell populations
CA2876692C (en) 2012-06-22 2022-05-24 Quantrx Biomedical Corporation Method for obtaining fetal cells and fetal cellular components
SG10201704008RA (en) * 2012-11-27 2017-06-29 The Children's Medical Center Corp Targeting Bcl11a Distal Regulatory Elements for Fetal Hemoglobin Reinduction
EP2979089B1 (de) 2013-03-27 2019-08-14 Theranos IP Company, LLC Verfahren, vorrichtungen und systeme zur probenanalyse
ES2938048T3 (es) 2013-07-24 2023-04-04 Streck Llc Composiciones y procedimientos para estabilizar las células tumorales circulantes
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
CN104977284B (zh) * 2015-07-03 2018-05-29 石莹 一种胎儿有核红细胞的捕获及鉴定方法
KR101794218B1 (ko) * 2015-08-19 2017-11-07 인제대학교 산학협력단 비침습적 산전 진단을 위한 산모 혈액 내 유핵 적혈구의 농축 분리 방법
WO2017057076A1 (ja) * 2015-09-28 2017-04-06 富士フイルム株式会社 有核赤血球の取得方法および有核赤血球の識別方法
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
WO2018022991A1 (en) 2016-07-29 2018-02-01 Streck, Inc. Suspension composition for hematology analysis control
JP6234542B1 (ja) 2016-12-27 2017-11-22 株式会社 ＴＬ Ｇｅｎｏｍｉｃｓ 胎児細胞由来染色体ｄｎａの取得方法
WO2019078277A1 (ja) 2017-10-19 2019-04-25 株式会社 ＴＬ Ｇｅｎｏｍｉｃｓ 細胞分級用チップ
CN109115584A (zh) * 2018-09-10 2019-01-01 首都医科大学附属北京妇产医院 一种检测红细胞中血红蛋白f的检测试剂及其应用
KR20230114327A (ko) * 2019-07-15 2023-08-01 메나리니 바이오마커스 싱가포르 피티이 리미티드 태아 세포의 단리, 검출 및 분석을 위한 조성물 및방법
CN111948404B (zh) * 2020-08-03 2023-04-07 融智生物科技（青岛）有限公司 用于筛查地中海贫血的特征蛋白标记组合物、质谱模型及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE162631T1 (de) * 1989-11-13 1998-02-15 Childrens Medical Center Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna
EP0662152A1 (de) * 1992-07-17 1995-07-12 Aprogenex, Inc. Anreichung und identifizierung fötaler zellen in mütterlichem blüt für in situ hybridisierung
US5457024A (en) * 1993-01-22 1995-10-10 Aprogenex, Inc. Isolation of fetal erythrocytes
AU7474394A (en) * 1993-07-19 1995-02-20 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5580724A (en) * 1994-03-25 1996-12-03 Board Of Regents, The University Of Texas System Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis

Also Published As

Publication number Publication date
DE69732662T2 (de) 2005-12-29
JP2001502805A (ja) 2001-02-27
US5731156A (en) 1998-03-24
EP1007965A1 (de) 2000-06-14
BR9712548A (pt) 1999-12-21
RU2178703C2 (ru) 2002-01-27
JP4091123B2 (ja) 2008-05-28
AU735380B2 (en) 2001-07-05
CA2269327A1 (en) 1998-04-30
IL129382A (en) 2002-09-12
WO1998018005A1 (en) 1998-04-30
AU4920097A (en) 1998-05-15
ATE290210T1 (de) 2005-03-15
KR20000052662A (ko) 2000-08-25
EP1007965B1 (de) 2005-03-02
CN1234117A (zh) 1999-11-03
EP1007965A4 (de) 2000-06-14
KR100523381B1 (ko) 2005-10-24
HK1031255A1 (en) 2001-06-08
IL129382A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
ATE290210T1 (de) Verwendung von antikörpern gegen embryonales hämoglobin zur identifizierung von fötalen zellen
Johnson et al. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis
AU2010237203B2 (en) Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome
WO2002055985A3 (en) Methods and reagents for identifying rare fetal cells in the material circulation
US20080108071A1 (en) Methods and Systems to Determine Fetal Sex and Detect Fetal Abnormalities
ATE322558T1 (de) Sensible und multiplexe diagnostische tests zur proteinanalyse
DE60024448D1 (de) System zur elektrochemischen quantitativen analyse von analyten in einer festphase
Fox-Fisher et al. Remote immune processes revealed by immune-derived circulating cell-free DNA
DE3650416T2 (de) Zelluläres verfahren zur bestimmung des originalen gewebes.
US11397180B2 (en) Methods and compositions for rapid functional analysis of gene variants
Waaijer et al. Do senescence markers correlate in vitro and in situ within individual human donors?
MX2008011665A (es) Diagnóstico y pronóstico de los estados patológicos asociados a la dipeptidil-peptidasa.
ATE513851T1 (de) Menschliches gen zur fruchtbarkeit entscheidend
MXPA96004278A (es) Expansion diferencial de celulas de baston fetalesen la circulacion materna para usarse en analisisgenetico prenatal.
JP2005506849A5 (de)
NO994358D0 (no) FramgangsmÕte for Õ identifisere eller isolere röde blodlegemer fra embryo eller foster
WO2001077379A3 (en) A method of cell detection
KR101138343B1 (ko) 알츠하이머 질병의 진단을 위한 신속한 시험법
CN110938700B (zh) 一种评价或辅助评价卵巢细胞的方法及其使用的标志物
Sonek et al. Identification of fetal aneuploidy with dual‐probe fluorescence in situ hybridization analysis in circulating trophoblasts after enrichment using a high‐sensitivity microfluidic platform
Liu et al. A human identification system for hair shaft using RNA polymorphism
KR102665392B1 (ko) 무증상 갑상선 저하증 진단용 조성물 및 이를 포함하는 키트
US20220081717A1 (en) Method for Counting Cell Types or Cell Markers In a Sample, In Particular In a Blood Sample
Abdelhanine et al. Using commercial enzyme immunoassay for measuring pregnancy-associated glycoproteins to diagnose pregnancy in dairy cows under field conditions in Algeria
CN118028093A (zh) 一种心肌梗死标志物的检测装置

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: APPLIED IMAGING, INC., SAN JOSE, CALIF., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee